Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation. No core study content or participant-facing information is affected.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new version of the page deployment. This appears to be a minor technical update rather than a change to the study content.SummaryDifference0.1%

- Check50 days agoChange DetectedA minor platform revision updated the page from v3.6.2 to v3.6.3, indicating behind-the-scenes changes to the site's code or rendering without altering displayed study information.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check72 days agoChange DetectedRecruitment status on the study page is updated to indicate no further participant enrollment ('No longer looking for participants'), and several new navigation/help sections are added (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change to the Intervention/Treatment heading and a new revision stamp 'Revision: v3.6.0' are also included.SummaryDifference0.5%

- Check79 days agoChange DetectedThe footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a system or site-wide update to the platform.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.